![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Impact of SVR on Liver Decompensation and Hepatic Fibrosis Markers in HIV/HCV
|
|
|
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
JP Tate1,2, EJ Wherry3, JR Kostman3, D Bhattacharya4, G Garcia-Tsao2, C Gibert5, JK Lim1,2, D Rimland6, AC Justice1,2, V Lo Re III3,7
1VA Connecticut Health System; 2Yale University School of Medicine; 3Center for AIDS Research, University of Pennsylvania; 4VA Greater Los Angeles; 5Washington DC VA Medical Center; 6Atlanta VA Healthcare System; 7Philadelphia VA Medical Center Research Supported by: National Institute on Alcohol Abuse and Alcoholism (U01 AA13566) and Agency for Healthcare Research and Quality (R01 HS018372)
![CROI1.gif](../images/032015/032015-4/CROI1.gif)
![CROI2.gif](../images/032015/032015-4/CROI2.gif)
![CROI3.gif](../images/032015/032015-4/CROI3.gif)
![CROI4.gif](../images/032015/032015-4/CROI4.gif)
![CROI5.gif](../images/032015/032015-4/CROI5.gif)
![CROI6.gif](../images/032015/032015-4/CROI6.gif)
![CROI7.gif](../images/032015/032015-4/CROI7.gif)
![CROI8.gif](../images/032015/032015-4/CROI8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|